摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Pseudoephedrine hydrobromide | 60706-27-6

中文名称
——
中文别名
——
英文名称
Pseudoephedrine hydrobromide
英文别名
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrobromide
Pseudoephedrine hydrobromide化学式
CAS
60706-27-6
化学式
C10H16BrNO
mdl
——
分子量
246.14
InChiKey
VGBAPRQRVHQDMK-KXNXZCPBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.91
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    32.3
  • 氢给体数:
    3
  • 氢受体数:
    2

文献信息

  • Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0421581A1
    公开(公告)日:1991-04-10
    The present invention pertains to a spray dried spheroidal microcapsule under about 150 microns in diameter which comprises (a) a medicament present in an amount from about 1% to about 90%, by weight of the microcapsule composition, (b) a film forming polymer present in an amount from about 8% to about 90%, by weight of the microcapsule composition, (c) a plasticizing agent in an amount from about 5% to about 30%, by weight of the film forming polymer. In another embodiment, the invention is directed at a spheroidal coated microcapsule under about 850 microns in diameter which comprises at least one spray dried spheroidal microcapsule core under about 150 microns in diameter and a coating layer over the core, wherein the coating layer comprises in percentages by weight of the coating layer composition (a) an edible material having a melting point from about 25o C. to about 100o C. selected from the group consisting of (i) fatty acids having an iodine value from about 1 to about 10, (ii) natural waxes, (iii) synthetic waxes, and (iv) mixtures thereof, present in an amount from about 80% to about 99.5%, and (b) a surface active agent present in an amount from about 0.5% to about 20%.
    本发明涉及一种直径小于约 150 微米的喷雾干燥球形微胶囊,它包括:(a) 一种药物,其含量为微胶囊组合物重量的约 1%至约 90%;(b) 一种成膜聚合物,其含量为微胶囊组合物重量的约 8%至约 90%;(c) 一种增塑剂,其含量为成膜聚合物重量的约 5%至约 30%。在另一个实施方案中,本发明涉及一种直径小于约 850 微米的球形包衣微胶囊,该微胶囊包括至少一个直径小于约 150 微米的喷雾干燥球形微胶囊芯和覆盖在芯上的包衣层,其中包衣层包括以重量百分比计的包衣层组合物 (a) 一种可食用材料,其熔点在约 25o C. 至约 100o C. 之间。(b) 一种表面活性剂,含量约为 0.5%至约 20%。
  • Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and method for preparing same
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0421582A1
    公开(公告)日:1991-04-10
    The present invention pertains to a spray dried spheroidal microcapsule under about 150 microns in diameter which comprises (a) a medicament present in an amount from about 1% to about 90%, by veight of the microcapsule composition, (b) a film forming polymer present in an amount from about 8% to about 90%, by weight of the microcapsule composition, and (c) a plasticizing agent present in an amount from about 5% to about 30%, by weight of the film forming polymer. In another embodiment, the invention is directed at a spheroidal coated microcapsule under about 850 microns in diameter which comprises at least one spray dried spheroidal microcapsule core under about 150 microns in diameter and a coating layer over the core, wherein the coating layer comprises (a) a film forming polymer, and (b) a plasticizing agent present in an amount from about 5% to about 30%, by weight of the film forming polymer.
    本发明涉及一种直径小于约 150 微米的喷雾干燥球形微胶囊,它包括:(a) 一种药物,其含量为微胶囊组合物重量的约 1%至约 90%;(b) 一种成膜聚合物,其含量为微胶囊组合物重量的约 8%至约 90%;(c) 一种增塑剂,其含量为成膜聚合物重量的约 5%至约 30%。在另一个实施方案中,本发明涉及一种直径小于约 850 微米的球形包衣微胶囊,它包括至少一个直径小于约 150 微米的喷雾干燥球形微胶囊芯和覆盖在芯上的包衣层,其中包衣层包括(a)成膜聚合物,和(b)增塑剂,按成膜聚合物的重量计,其含量从约 5%到约 30%。
  • Chewable spheroidal coated microcapsules and methods for preparing same
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0477135A1
    公开(公告)日:1992-03-25
    The present invention pertains to a chewable spheroidal coated microcapsule under about 850 microns in diameter which comprises at least one spray congealed spheroidal microcapsule core under about 200 microns in diameter, a first wax spray coating layer over the core, and a second oil coating layer over the first coated core, wherein the coated microcapsule comprises (A) a microcapsule core comprising, in percentages by weight of the microcapsule core (a) a medicament present in an amount from about 1% to about 40%, (b) an edible material having a melting point from about 25°C. to about 100°C. selected from the group consisting of (i) fatty acids having an iodine value from about 1 to about 10, (ii) natural waxes, (iii) synthetic waxes, and (iv) mixtures thereof, present in an amount from about 9.5% to about 98.5%, (c) an emulsifying agent present in an amount from about 0.5% to about 20%, (B) a first wax spray coating layer over the microcapsule core comprising, in percentages by weight of the first coating layer (a) an edible material having a melting point from about 25°C. to about 100°C. selected from the group consisting of (i) fatty acids having an iodine value from about 1 to about 10, (ii) natural waxes, (iii) synthetic waxes, and (iv) mixtures thereof, present in an amount from about 60% to about 99.5%, (b) an emulsifying agent present in an amount from about 0.5% to about 20%, and (C) a second oil coating layer over the first coated microcapsule core comprising an edible vegetable oil having a melting point in the range from about 25°C. to about 90°C.
    本发明涉及一种直径小于约850微米的可咀嚼球形包衣微胶囊,它包括至少一个直径小于约200微米的喷雾凝固球形微胶囊芯,在该芯上有第一喷蜡包衣层,以及在第一包衣芯上有第二喷油包衣层、其中包衣微胶囊包括 (A) 微胶囊芯,以微胶囊芯的重量百分比计 (a) 药物,其含量从约1%到约40%; (b) 可食用材料,其熔点从约25°C.至约 100°C.的可食用材料,选自以下组别:(i) 值在约 1 至约 10 之间的脂肪酸;(ii) 天然蜡;(iii) 合成蜡;(iv) 它们的混合物,含量在约 9.(B) 微胶囊芯上的第一喷蜡涂层,以第一涂层的重量百分比计包括 (a) 一种可食用材料,其熔点为约 25°C 至约 100°C。(b) 一种乳化剂,含量约为 0.5%至约 20%;以及 (C) 覆盖在第一涂层微胶囊芯上的第二油涂层层,包括熔点在约 25°C 至约 90°C 范围内的可食用植物油。
  • US5167964A
    申请人:——
    公开号:US5167964A
    公开(公告)日:1992-12-01
  • US5656296A
    申请人:——
    公开号:US5656296A
    公开(公告)日:1997-08-12
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫